We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MaxCyte, Inc. 23 December 2024 MaxCyte Announces Retirement of Board Member Art Mandell ROCKVILLE, MD, December 23, 2024 - MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading...
ROCKVILLE, Md., Dec. 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...
MaxCyte, Inc. 19 December 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
MaxCyte, Inc. 18 December 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
MaxCyte, Inc. 10 December 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
MaxCyte, Inc. 10 December 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
MaxCyte Inc on Monday said the current year has been good for the company as it upgraded its core revenue guidance fo ...
MaxCyte, Inc. 09 December 2024 MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance ROCKVILLE, MD, December 9, 2024 - MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a...
ROCKVILLE, Md., Dec. 08, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading cell-engineering focused company providing enabling platform technologies to advance the...
MaxCyte, Inc. 02 December 2024 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights and Block Listing Return ROCKVILLE, MD, December 2, 2024: MaxCyte Inc., (Nasdaq: MXCT;...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 17 | 5.26315789474 | 323 | 334 | 320 | 6111 | 327.89466507 | DE |
4 | 65 | 23.6363636364 | 275 | 346 | 275 | 26775 | 305.30783053 | DE |
12 | 56 | 19.7183098592 | 284 | 346 | 256 | 41456 | 282.90459465 | DE |
26 | 18 | 5.5900621118 | 322 | 380 | 256 | 25526 | 290.52828785 | DE |
52 | -30 | -8.10810810811 | 370 | 420 | 256 | 28157 | 333.34611509 | DE |
156 | -430 | -55.8441558442 | 770 | 785 | 172.5 | 38606 | 403.7469238 | DE |
260 | 222.5 | 189.361702128 | 117.5 | 1230 | 115 | 84435 | 571.13330721 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions